miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215
Open Access
- 27 October 2011
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 105 (11), 1741-1749
- https://doi.org/10.1038/bjc.2011.401
Abstract
Background: Method: Results: Conclusion:Keywords
This publication has 44 references indexed in Scilit:
- MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancerBMC Medicine, 2010
- The VHL-dependent regulation of microRNAs in renal cancerBMC Medicine, 2010
- Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancerBritish Journal of Cancer, 2010
- The Roles of MicroRNAs in the Cancer Invasion-Metastasis CascadeCancer Microenvironment, 2010
- From bench to bedside: current and future applications of molecular profiling in renal cell carcinomaMolecular Cancer, 2009
- p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle ArrestCancer Research, 2008
- miRecords: an integrated resource for microRNA-target interactionsNucleic Acids Research, 2008
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2Genes & Development, 2008
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004